Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2003-05-26
2008-12-02
Kam, Chih-Min (Department: 1656)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600, C530S350000, C424S009100
Reexamination Certificate
active
07459433
ABSTRACT:
The present invention relates to the field of obesity research. Obesity is a public health problem that is serious and widespread. A compound, homotrimer of OBG3 polypeptide fragment comprising globular domain and all or part of OBG3 collagen-like region, has been identified that has utility for reducing body mass, for maintaining weight loss, and for treating obesity-related diseases and disorders. These obesity-related diseases and disorders include hyperlipidemias, atherosclerosis, diabetes, and hypertension.
REFERENCES:
patent: 6344441 (2002-02-01), Bihain et al.
patent: 6566332 (2003-05-01), Fruebis et al.
patent: 6579852 (2003-06-01), Fruebis et al.
patent: 6635431 (2003-10-01), Bihain et al.
patent: 6867189 (2005-03-01), Lucas et al.
patent: 6946444 (2005-09-01), Bihain et al.
patent: 6967091 (2005-11-01), Fruebis et al.
patent: 6989367 (2006-01-01), Fruebis et al.
patent: 2002/0058617 (2002-05-01), Fruebis et al.
patent: 2002/0151498 (2002-10-01), Bihain et al.
patent: 2004/0077051 (2004-04-01), Bihain et al.
patent: 2005/0065079 (2005-03-01), Scalla et al.
patent: 2005/0075285 (2005-04-01), Bour et al.
patent: 2005/0288223 (2005-12-01), Lucas et al.
patent: 2006/0293225 (2006-12-01), Dialynas et al.
patent: 2007/0054845 (2007-03-01), Chumakov et al.
patent: WO 99 07736 (1999-02-01), None
patent: WO 99/07737 (1999-02-01), None
patent: WO 01 51645 (2001-07-01), None
patent: WO 02/069689 (2002-09-01), None
patent: WO 03 010197 (2003-02-01), None
patent: WO 03/010314 (2003-02-01), None
patent: WO 03 010314 (2003-02-01), None
patent: WO 03/033534 (2003-04-01), None
patent: WO 03/050281 (2003-06-01), None
patent: WO 03 055916 (2003-07-01), None
patent: WO 03/097689 (2003-11-01), None
Tsao et al. “Role of disulfide bonds in Acrp30/Adiponectin structure and signaling specificity,” The J. of Biol. Chem., vol. 278, No. 50, pp. 50810-50817, Dec. 12, 2003.
Fruebis, J. et al., “Proteolytic Cleavage Product of 30-kDa Adipocyte Complement-Related Protein Increases Fatty Acid Oxidation in Muscle and Causes Weight Loss in Mice”,PNAS, Feb. 13, 2001, pp. 2005-2010, vol. 98, No. 4.
Wong, G.W. et al. “A family of Acrp30/adiponectin structural and functional paralogs”,PNAS, Jul. 13, 2004, pp. 10302-10307, vol. 101, No. 28.
Dialynas Deno
Lucas John
Yeh Jiunn-chern
Kam Chih-Min
Saliwanchik Lloyd & Saliwanchik
Serono Genetics Institute S.A.
LandOfFree
Homotrimeric extended OBG3 globular head and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Homotrimeric extended OBG3 globular head and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Homotrimeric extended OBG3 globular head and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4045262